CML: ‘This thing is not going to be the end of my life’ [Video]

One of the most critical components of successful and effective health care is the relationship between a patient and their healthcare provider. This includes the ability to communicate openly and honestly when it comes to treatment goals, and for the patient, having a role in decision-making.

In 2022, pharmaceutical company Novartis surveyed people living with chronic myeloid leukemia (CML) — a rare blood cancer — as well as the doctors who treat CML. The survey, known as CML SUN (CML Survey of Unmet Needs), gathered insights from 361 patients and 198 physicians (hematologists and/or oncologists) in 11 countries (Australia, Brazil, Canada, France, Germany, Italy, Japan, South Korea, Spain, the UK, and the U.S.) from November 2022 to March 2023. The findings revealed that there needs to be more communication and shared decision-making between patients and treatment providers; patients need therapy options that are both effective and tolerable; and that discussions between doctors …